Primary Care’s Role in Skin Cancer Detection

Expert panelists discuss the essential role of primary care in early skin cancer detection, balancing clinical judgment with emerging AI artificial intelligence tools, and more.

The Role of Extended HPV Genotyping In Managing High Risk Patients
May 02, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.

Adolescent Hyperglycemia, Insulin Resistance Drive Early Cardiac Structural Changes, Novel Cohort Study Finds
May 02, 2025

Persistent hyperglycemia between ages 17 and 24 tripled the risk of left ventricular hypertrophy and did so 5 times faster among young women, a new study found.

"It Costs Too Much," Americans Say About Skipping Necessary Medical Care: Survey Findings
May 02, 2025

Affordability is pushing an increase in deferred care — even among the insured —and physicians are feeling the effects.

Dupilumab Approved for Uncontrolled Chronic Spontaneous Urticaria: Daily Dose
May 02, 2025

Your daily dose of the clinical news you may have missed.

Direct Mail to Older Adults at Risk for Pneumococcal Disease Improves Vaccination Rates
May 02, 2025

A mail campaign targeting adults with chronic conditions as well as their GPs increased the number receiving at least 1 shot by 9.5 percentage points.

Peripheral Artery Disease in Primary Care: Expert Insights on Recognition & Risk Factors
May 01, 2025

ACP 2025: Foluso Fakorede, MD, discusses the importance of recognizing and screening for peripheral artery disease in primary care.

New Data on Dupilumab Reinforces Its Impact on Chronic Respiratory Diseases
May 01, 2025

New clinical trial findings to be presented at ATS 2025 highlights the effectiveness of dupilumab in treating COPD and asthma.

FDA Approves STS101 (Dihydroergotamine) Nasal Powder for Acute Treatment of Migraine
May 01, 2025

The only approved DHE nasal powder addresses persistent limitations of existing DHE formulations, including liquid nasal sprays and injectables, Satsuma stated.

Millions of US Adults Have Multiple Forms of Eczema, Study Finds
May 01, 2025

Nearly 1 in 10 US adults have eczema, with 18% experiencing multiple eczema conditions, researchers from the National Eczema Association reported.

Mepolizumab Reduces AER in COPD Leading to Emergency Care by 35%: MATINEE Findings Published in NEJM
May 01, 2025

Mepolizumab also cut annualized exacerbation rates by 21% across the full study cohort and by 31% in a subgroup of participants with chronic bronchitis only.